Biotechnology | COVID-19 | NIH | Vaccine
Emory University Began enrolling older adults in COVID-19 vaccine clinical trial
On Apr. 17, 2020, Emory University announced it had begun enrolling adults over age 55 in the clinical…
-
-
Biotechnology | NIH | Oncology | Therapeutics
Roswell Park’s Dr. Pawel Kalinski lead $14.5 million NCI-funded immunotherapy effort
On Apr. 16, 2020, a team led by Pawel Kalinski, MD, PhD, of Roswell Park Comprehensive Cancer Center…
-
Researchers restored sight in mice by turning skin cells into light-sensing eye cells
On Apr. 15, 2020, researchers have discovered a technique for directly reprogramming skin cells into light-sensing rod photoreceptors…
-
A gut-to-brain circuit drives sugar preference and may explain sugar cravings
On Apr. 15, 2020, Howard Hughes Medical Institute (HHMI) investigators report the sensation of sweetness starts on the…
-
NIH began study to quantify undetected cases of coronavirus infection
On Apr. 10, 2020, a new study has begun recruiting at the NIH in Bethesda, Maryland, to determine…
-
Novavax identified Coronavirus vaccine candidate; accelerated initiation of first-in-human trial to mid-May
On Apr. 8, 2020, Novavax announced it had identified a coronavirus vaccine candidate, NVX-CoV2373, a stable, prefusion protein…
-
Emergent BioSolutions partnered with U.S. Government to expedite development of plasma-derived therapy for COVID-19
On Apr. 2, 2020, Emergent BioSolutions announced it had entered into a formal partnership with the U.S. government…
-
The FDA announced publication of ARGOS SARS-CoV-2 reference grade sequence data
On Apr. 2, 2020, the FDAﾗin collaboration with the CDC, the Biodefense and Emerging Infections Research Resources Repository…
-
Emergent BioSolutions signed agreement with Novavax to manufacture NanoFlu
On Mar. 31, 2020, Emergent BioSolutions announced an agreement with Novavax whereby Emergent provided molecule-to-market contract development and…
-
Altimmune and the University of Alabama at Birmingham to collaborate on development of single-dose, intranasal COVID-19 vaccine
On Mar. 30, 2020, Altimmune announced that it was launching a collaboration with the University of Alabama at…
-
Novavax NanoFlu achieved all primary endpoints in phase 3 clinical trial
On Mar. 24, 2020, Novavax announced positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu,…
-
NIH shifted non-mission-critical laboratory operations to minimal maintenance phase
On Mar. 20, 2020, to further reduce the risk of transmission of COVID-19 and enhance the safety of…
-
Emergent Biosolutions signed development and manufacturing agreement with Vaxart for experimental Coronavirus oral vaccine
On Mar. 18, 2020, Emergent BioSolutions announced an agreement with Vaxart, whereby Emergent has agreed to utilize its…
-
NIH Reported First Known Employee with COVID-19 Infection
On Mar. 15, 2020, the National Institutes of Health (NIH) informed its staff that it had its first…
-
Newer anti-HIV drugs safest, most effective during pregnancy
On Mar. 11, 2020, the antiretroviral drugs dolutegravir and emtricitabine/tenofovir alafenamide fumarate (DTG+FTC/TAF) may comprise the safest and…
-
Emergent BioSolutions initiated development of product candidates for treatment of Coronavirus
On Mar. 11, 2020, Emergent BioSolutions announced it has initiated development of two product candidates for treatment and…
-
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
Testing with combined biopsy method improves prostate cancer diagnosis in NCI study
On Mar. 4, 2020, a method of testing for prostate cancer developed at the National Cancer Institute (NCI)…
-
Novavax advanced development of novel COVID-19 vaccine
On Feb. 26, 2020, Novavax announced progress in its efforts to develop a novel vaccine to protect against…
-
Bavarian Nordic Announces U.S. FDA Approval of JYNNEOS™ Vaccine for Prevention of Smallpox and Mpox
On Sept. 24, 2019, Bavarian Nordic announced that the U.S. Food and Drug Administration (FDA) had approved JYNNEOS™…
-
MouseLight Project mapped 1,000 neurons in the mouse brain
On Sept. 5, 2019, researchers at the Howard Hughes Medical Institute’s Janelia Research Campus announced that they had…
-
Vaccitech universal flu vaccine passed Phase 2b clinical development milestones
On Jun. 5, 2019, Vaccitech announced that it had administered its pandemic universal influenza A vaccine MVA-NP+M1 (VTP-100)…
-
Biotechnology | Diagnostics | NIH | Non-Profit Research | Oncology | Radiology | Therapeutics | U.S. Congress
The National Cancer Institute Annual Report to the Nation found cancer death rates continue to drop
On May 30, 2019, a report from the nation’s leading cancer organizations found that Americans’ risk of dying…
-
Complete fly brain imaged at nanoscale resolution
On Jul. 19, 2018, scientists at Howard Hughes Medical Institute (HHMI) announced detailed imaging of the entire brain…
-
FDA approved first drug comprised of an active ingredient derived from marijuana to treat epilepsy
On Jun. 25, 2018, the U.S. Food and Drug Administration (FDA) approved Epidiolex (cannabidiol) [CBD] oral solution for…
-
TAILOR trial found most women with early breast cancer do not benefit from chemotherapy
On Jun. 3, 2018, findings were reported from the groundbreaking Trial Assigning Individualized Options for Treatment (Rx), or…
-
Biotechnology | Diagnostics | Disease | Genomics | Medicine | NIH | Non-Profit Research | Oncology | Therapeutics
NIH completed in-depth genomic analysis of 33 cancer types
On Apr. 5, 2018, researchers funded by the National Institutes of Health (NIH) announced they had completed a…
-
Biotechnology | FDA | Therapeutics | Vaccine
The FDA unveiled a strategic plan to completely eliminate the agency’s existing orphan designation backlog
On Jun. 29, 2017, the U.S. Food and Drug Administration unveiled a strategic plan to completely eliminate the…
-
Biotechnology | CDC | Diagnostics | Infectious Disease | Influenza | NIH | Non-Profit Research | U.S. Congress | Vaccine | Veterinary
HHS Influenza Pandemic Planning Update was published
On Jun. 15, 2017, the U.S. Department of Health and Human Services (HHS) published the nations’s updated Pandemic…
-
Biotechnology | Diagnostics | Neurology | NIH
The Cleveland Clinic received a $6 million NIH grant to establish a national research consortium for studying Lewy Body Dementia
On Jun. 13, 2017, the National Institutes of Health (NIH) awarded a $6 million grant to Cleveland Clinic…
-
PharmAthene and Altimmune announced merger to create immunotherapeutics company targeting infectious diseases
On Jan. 19, 2017, PharmAthene and Altimmune, a privately-held immunotherapeutics company targeting infectious diseases, announced an agreement for…
